Financhill
Back

Genmab AS Stock Predictions

Genmab AS Stock Forecast

  • Over the next 52 weeks, Genmab AS has on average historically risen by 32.8% based on the past 12 years of stock performance.
  • Genmab AS has risen higher in 7 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 58.33%
  • Is Genmab AS Stock Undervalued?
    The current Genmab AS [GMAB] share price is $22.34. The Score for GMAB is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • GMAB is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Genmab AS Stock Go Up Next Year?

  • Over the next 52 weeks, Genmab AS has on average historically risen by 32.8% based on the past 12 years of stock performance.

Genmab AS Stock Rating

Buy
60
Genmab AS (GMAB) is a Buy

Is Genmab AS overpriced?

  • Genmab AS has risen higher in 7 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 58.33%

Genmab AS Stock Price History

Is GMAB stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GMAB is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Denmark
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
genmab.com

52-Week Data

52-Week High:
31.88
52-Week Low:
18.64

Prediction Charts

Market Cap:
14.2B
Price in USD:
22.34
Volume:
1.1M
Beta:
0.70

Technical Analysis

SMA50:
20.74
SMA100:
21.60
SMA200:
24.41
52-Wk Change:
-22.83%

Stock Predictions

  • Is Genmab AS stock public?
    Yes, Genmab AS is a publicly traded company.
  • What is the Genmab AS stock quote today?
    The Genmab AS stock price is 22.34 USD today.
  • How to buy Genmab AS stock online?
    You can buy Genmab AS shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Feb-3 19.10 19.11 19.37 19.00
Feb-4 19.19 19.21 19.43 19.13
Feb-5 19.30 19.47 19.63 19.30
Feb-6 19.31 19.35 19.47 19.15
Feb-7 19.29 19.00 19.36 18.92
Feb-10 18.93 18.69 19.02 18.64
Feb-11 19.05 18.89 19.13 18.87
Feb-12 18.87 19.69 19.71 18.74
Feb-13 20.11 20.92 20.98 20.03
Feb-14 21.08 21.30 21.31 21.01
Feb-18 21.34 21.77 21.79 21.30
Feb-19 21.45 21.97 22.06 21.45
Feb-20 22.07 22.44 22.55 22.07
Feb-21 22.32 22.34 22.36 22.07

Genmab AS Earnings

Genmab AS Earnings Report: Per Share Genmab AS Earnings Q1 Q2 Q3 and Q4 last year and next year.

Genmab AS Forecast Revenue Growth

Genmab AS Stock Analysis: Historical quarterly revenues per share for Genmab AS and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.14 per share, an increase next quarter of $5.18 per share, an increase this year of $0.23 per share, and an increase next year of $0.28 per share.

* Genmab AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.